Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.

MLA

Wang, Beilei, et al. “Platinated Benzonaphthyridone Is a Stronger Inhibitor of Poly(ADP-Ribose) Polymerase-1 and a More Potent Anticancer Agent than Is the Parent Inhibitor.” European Journal of Medicinal Chemistry, vol. 71, Jan. 2014, pp. 366–73. EBSCOhost, https://doi.org/10.1016/j.ejmech.2013.10.062.

APA

Wang, B., Qian, H., Yiu, S.-M., Sun, J., & Zhu, G. (2014). Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor. European Journal of Medicinal Chemistry, 71, 366–373. https://doi.org/10.1016/j.ejmech.2013.10.062

Chicago

Wang, Beilei, Hui Qian, Shek-Man Yiu, Jianwei Sun, and Guangyu Zhu. 2014. “Platinated Benzonaphthyridone Is a Stronger Inhibitor of Poly(ADP-Ribose) Polymerase-1 and a More Potent Anticancer Agent than Is the Parent Inhibitor.” European Journal of Medicinal Chemistry 71 (January): 366–73. doi:10.1016/j.ejmech.2013.10.062.